LHC Group (NASDAQ:LHCG) Given a $135.00 Price Target by Royal Bank of Canada Analysts

Royal Bank of Canada set a $135.00 price target on LHC Group (NASDAQ:LHCG) in a research note published on Friday, TipRanks reports. The brokerage currently has a buy rating on the health services provider’s stock.

A number of other research firms have also commented on LHCG. BidaskClub upgraded shares of LHC Group from a buy rating to a strong-buy rating in a report on Friday, August 2nd. Zacks Investment Research upgraded shares of LHC Group from a hold rating to a buy rating and set a $130.00 price target for the company in a report on Thursday, June 27th. Jefferies Financial Group upped their price target on shares of LHC Group from $125.00 to $130.00 and gave the company a buy rating in a report on Thursday, May 9th. Barclays upped their price target on shares of LHC Group from $113.00 to $120.00 and gave the company an equal weight rating in a report on Friday. Finally, Oppenheimer upped their price target on shares of LHC Group from $125.00 to $146.00 and gave the company an outperform rating in a report on Friday. Three equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of Buy and a consensus price target of $126.73.

Shares of LHC Group stock traded down $5.34 during trading on Friday, reaching $117.49. The company’s stock had a trading volume of 165,883 shares, compared to its average volume of 245,579. LHC Group has a 52-week low of $80.84 and a 52-week high of $129.37. The company has a market cap of $3.71 billion, a P/E ratio of 33.10, a price-to-earnings-growth ratio of 2.08 and a beta of 0.84. The firm has a 50-day simple moving average of $121.74. The company has a current ratio of 1.59, a quick ratio of 1.57 and a debt-to-equity ratio of 0.20.

LHC Group (NASDAQ:LHCG) last announced its quarterly earnings data on Wednesday, August 7th. The health services provider reported $1.07 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.01 by $0.06. LHC Group had a net margin of 4.20% and a return on equity of 8.83%. The company had revenue of $517.84 million during the quarter, compared to analysts’ expectations of $524.24 million. During the same quarter in the prior year, the company earned $0.84 EPS. The firm’s revenue was up 3.2% on a year-over-year basis. As a group, analysts predict that LHC Group will post 4.33 EPS for the current fiscal year.

In other LHC Group news, Director John L. Indest sold 30,515 shares of the company’s stock in a transaction on Thursday, June 6th. The shares were sold at an average price of $113.76, for a total value of $3,471,386.40. Following the completion of the transaction, the director now directly owns 22,947 shares in the company, valued at approximately $2,610,450.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Donald Dwayne Stelly sold 448 shares of the company’s stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $120.00, for a total transaction of $53,760.00. Following the completion of the transaction, the chief operating officer now owns 91,252 shares of the company’s stock, valued at $10,950,240. The disclosure for this sale can be found here. Insiders sold a total of 46,269 shares of company stock valued at $5,314,613 over the last 90 days. Company insiders own 5.20% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the business. BlackRock Inc. increased its stake in shares of LHC Group by 2.6% in the 1st quarter. BlackRock Inc. now owns 4,686,353 shares of the health services provider’s stock worth $519,530,000 after acquiring an additional 120,016 shares in the last quarter. FMR LLC increased its stake in shares of LHC Group by 2.4% in the 1st quarter. FMR LLC now owns 1,151,105 shares of the health services provider’s stock worth $127,612,000 after acquiring an additional 27,272 shares in the last quarter. OppenheimerFunds Inc. increased its stake in shares of LHC Group by 3.1% in the 1st quarter. OppenheimerFunds Inc. now owns 502,757 shares of the health services provider’s stock worth $55,735,000 after acquiring an additional 15,013 shares in the last quarter. Rothschild & Co. Asset Management US Inc. increased its stake in shares of LHC Group by 0.8% in the 1st quarter. Rothschild & Co. Asset Management US Inc. now owns 459,400 shares of the health services provider’s stock worth $50,929,000 after acquiring an additional 3,722 shares in the last quarter. Finally, Victory Capital Management Inc. bought a new position in shares of LHC Group in the 1st quarter worth about $42,215,000. Institutional investors and hedge funds own 91.73% of the company’s stock.

About LHC Group

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Further Reading: Understanding Market Liquidity

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit